Literature DB >> 2474594

Human T cell activation by phorbol esters and diacylglycerol analogues.

N Berry1, K Ase, U Kikkawa, A Kishimoto, Y Nishizuka.   

Abstract

Activation of protein kinase C (PKC), by the phorbol ester PMA, or the membrane-permeable diacylglycerol 1-oleoyl 2-acetylglycerol (OAG), had different effects on the proliferation-associated responses of a more than 99% pure population of human T cells. Treatment with PMA or OAG caused down-regulation of the TCR-CD3 complex, but only PMA, in combination with ionomycin, was capable of stimulating IL-2R expression and proliferation. Immunocytochemical staining with antisera specific for the PKC subspecies alpha, beta I, beta II, and gamma showed that untreated resting T cells normally coexpress alpha, beta I, and beta II PKC subspecies, which are distributed diffusely throughout the cell, with some localization around the periphery of the nucleus. There was no difference between the responses of these PKC subspecies to OAG and PMA, redistributing, after 10 min of treatment, to a discrete focal area within the cell. Treatment with OAG resulted in transient redistribution of PKC, maximal at 10 min, while in PMA-stimulated cells, the PKC redistribution was prolonged, persisting for at least 24 h. The results suggest that the difference in cellular response to treatment with PMA and OAG is not a consequence of differential activation of various PKC subspecies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474594

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Intracellular free Ca2+ fluxes and responses to phorbol ester in T lymphocytes from healthy elderly subjects.

Authors:  J R Naylor; S R James; L K Trejdosiewicz
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

2.  Different protein kinase C isoforms are present in the yeast and mycelium forms of Sporothrix schenckii.

Authors:  E E Aquino-Piñero; N Rodríguez del Valle
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

3.  Activation of resting human T cells requires prolonged stimulation of protein kinase C.

Authors:  N Berry; K Ase; A Kishimoto; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Force spectroscopy of LFA-1 and its ligands, ICAM-1 and ICAM-2.

Authors:  Ewa P Wojcikiewicz; Midhat H Abdulreda; Xiaohui Zhang; Vincent T Moy
Journal:  Biomacromolecules       Date:  2006-11       Impact factor: 6.988

5.  Metabolic rate of membrane-permeant diacylglycerol and its relation to human resting T-lymphocyte activation.

Authors:  Y Asaoka; M Oka; K Yoshida; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Translocation of spectrin and protein kinase C to a cytoplasmic aggregate upon lymphocyte activation.

Authors:  C C Gregorio; R T Kubo; R B Bankert; E A Repasky
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

7.  12-Deoxyphorbol-13-O-phenylacetate 20 acetate [an agonist of protein kinase C beta 1 (PKC beta 1)] induces DNA synthesis, interleukin-2 (IL-2) production, IL-2 receptor alpha-chain (CD25) and beta-chain (CD122) expression, and translocation of PKC beta isozyme in human peripheral blood lymphocytes: evidence for a role of PKC beta 1 in human T cell activation.

Authors:  S Aggarwal; S Lee; A Mathur; S Gollapudi; S Gupta
Journal:  J Clin Immunol       Date:  1994-07       Impact factor: 8.317

8.  Modulation of intracellular calcium concentrations and T cell activation by prickly pear polyphenols.

Authors:  Virginie Aires; Sylvie Adote; Aziz Hichami; Kabirou Moutairou; Es-Saddik E Boustani; Naim A Khan
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

9.  Protein kinase C activation in human monocytes: regulation of PKC isoforms.

Authors:  Z L Chang; D H Beezhold
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

10.  Anti-CD3-induced changes in protein kinase C isozymes expression in human CD4+ and CD8+ T lymphocytes.

Authors:  W Harris; S Gollapudi; S Gupta
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.